ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,038Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 886

$1.43M Total Retail Price of All Prescriptions

Rank: 3 out of 886

1,488 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 19,841 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ATORVASTATIN CALCIUM 2,250 2,148 10 1 9
ATENOLOL 1,666 1,584 10 2 13
METOPROLOL TARTRATE 1,218 1,166 3 1
PRAVASTATIN SODIUM 897 835 4 16
AMLODIPINE BESYLATE 813 784 5 8
CLOPIDOGREL 796 759 6 10
DIGOXIN 696 656 7 12
LISINOPRIL 676 620 8 3
FUROSEMIDE 644 602 9 5
PLAVIX 576 546 10 14
WARFARIN SODIUM 536 465 11 6
SIMVASTATIN 531 503 12 2
CRESTOR 496 483 13 15
ENALAPRIL MALEATE 434 426 14 30
HYDROCHLOROTHIAZIDE 404 390 15 18
CARVEDILOL 401 349 16 7
ISOSORBIDE MONONITRATE ER 379 340 17 11
LOSARTAN POTASSIUM 374 338 18 17
PRADAXA 364 360 19 21
LIPITOR 298 290 20 38
DILTIAZEM 24HR ER 291 281 21 23
ZETIA 286 279 22 20
NITROSTAT 284 266 23 31
POTASSIUM CHLORIDE 233 208 24 24
MULTAQ 227 224 25 42
LEVOTHYROXINE SODIUM 205 198 26 27
METOPROLOL SUCCINATE 194 194 27 4
LOVASTATIN 188 184 28 47
SOTALOL 186 179 29 29
DIOVAN 178 164 30 19
AMIODARONE HCL 156 136 31 26
XARELTO 151 151 32 57
SPIRONOLACTONE 143 116 33 22
BENICAR 136 130 34 71
DILTIAZEM 24HR CD 126 119 35 32
KLOR-CON M20 119 97 36 35
OMEPRAZOLE 112 88 37 28
TRICOR 111 108 38 61
QUINAPRIL HCL 107 104 39 43
VERAPAMIL ER 101 94 40 44
FELODIPINE ER 95 93 41 112
CILOSTAZOL 92 89 42 90
NIASPAN 89 86 43 37
RAMIPRIL 88 70 44 25
FAMOTIDINE 80 80 45 91
GEMFIBROZIL 78 74 46 117
NEXIUM 78 78 46 67
ALLOPURINOL 64 64 48 63
FLECAINIDE ACETATE 61 56 49 53
METFORMIN HCL 60 59 50 39
NITROGLYCERIN PATCH 58 58 51 54
TRAMADOL HCL 58 58 51 82
TAMSULOSIN HCL 52 46 53 83
BENICAR HCT 52 43 53 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.